Epidemiology of Idiopathic Central Serous Chorioretinopathy in Taiwan, 2001-2006: A Population-based Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tsai, Der Chong ^a   Chen, Shih Jen ^b   Huang, Chin Chou ^a,b   Chou, Pesus ^a   Chung, Chia Min ^c   Huang, Po Hsun ^a,b   Lin, Shing Jong ^a,b   Chen, Jaw Wen ^a,b   Chen, Tseng Ji ^a,b   Leu, Hsin Bang ^a,b   Chan, Wan Leong ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CORTICOSTEROID;

ADULT; AGE; ARTICLE; CENTRAL SEROUS RETINOPATHY; CONTROLLED STUDY; DATA BASE; DRUG EXPOSURE; FEMALE; GENDER; HEALTH INSURANCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; RANDOMIZATION; RISK FACTOR; SEX DIFFERENCE; TAIWAN;

ADULT; CASE-CONTROL STUDIES; CENTRAL SEROUS CHORIORETINOPATHY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; TAIWAN; YOUNG ADULT;

EID: 84879496713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066858     Document Type: Article

References (29)

1. Wang M, Munch IC, Hasler PW, Prunte C, Larsen M, (2008) Central serous chorioretinopathy. Acta Ophthalmologica 86: 126-145.
2. Gemenetzi M, De Salvo G, Lotery AJ, (2010) Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye 24: 1743-1756.
3. Ross A, Ross AH, Mohamed Q, (2011) Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 22: 166-173.
4. Yannuzzi LA, (1987) Type A behavior and central serous chorioretinopathy. Retina 7: 111-131.
5. Gelber GS, Schatz H, (1987) Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 144: 46-50.
6. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI, (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111: 1229-1233.
7. Wakakura M, Ishikawa S, (1984) Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 68: 329-331.
8. Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, et al. (1999) Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 128: 63-68.
9. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S, et al. (2004) Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111: 244-249.
10. Bouzas EA, Karadimas P, Pournaras CJ, (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47: 431-448.
11. Wakakura M, Song E, Ishikawa S, (1997) Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 41: 180-185.
12. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, Spaide RF, Freund KB, et al. (2002) Corticosteroids and central serous chorioretinopathy. Ophthalmology 109: 1834-1837.
13. Karadimas P, Bouzas EA, (2004) Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol 242: 800-802.
14. Quillen DA, Gass DM, Brod RD, Gardner TW, Blankenship GW, et al. (1996) Central serous chorioretinopathy in women. Ophthalmology 103: 72-79.
15. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, et al. (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103: 2070-2079.
16. Fukunaga K, (1969) Central chorioretinopathy with disharmony of the autonomous nerve system. Nihon Ganka Gakkai Zasshi 73: 1468-1477.
17. Desai UR, Alhalel AA, Campen TJ, Schiffman RM, Edwards PA, et al. (2003) Central serous chorioretinopathy in African Americans. J Natl Med Assoc 95: 553-559.
18. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP, (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 115: 169-173.
19. National Health Insurance Research Database. Available at: http://nhird.nhri.org.tw/en/Research.html. Accessed 18 December 2012.
20. Leveque TK, Yu L, Musch DC, Chervin RD, Zacks DN, (2007) Central serous chorioretinopathy and risk for obstructive sleep apnea. Sleep Breath 11: 253-257.
21. Chan WM, Lai TY, Tano Y, Liu DT, Li KK, et al. (2006) Photodynamic therapy in macular diseases of asian populations: when East meets West. Jpn J Ophthalmol 50: 161-169.
22. Conrad R, Bodeewes I, Schilling G, Geiser F, Imbierowicz K, et al. (2000) Chorioretinopathia centralis serosa und psychische Belastung. Ophthalmologe 97: 527-531.
23. Kirschbaum C, Wust S, Hellhammer DH, (1992) Consistent sex differences in cortisol responses to psychological stress. Psychosom Med 54: 648-657.
24. Harbin TJ, (1989) The relationship between the type A behavior pattern and physiological responsivity: a quantitative review. Psychophysiology 26: 110-119.
25. Hu CC, Ho JD, Lin HC, (2009) Retinal vein occlusion and the risk of acute myocardial infarction: a 3-year follow-up study. Br J Ophthalmol 93: 717-720.
26. Hu CC, Ho JD, Lin HC, (2010) Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study. Stroke 41: 613-617.
27. Chou KT, Huang CC, Tsai DC, Chen YM, Perng DW, et al. (2012) Sleep Apnea and Risk of Retinal Vein Occlusion: A Nationwide Population-Based Study of Taiwanese. Am J Ophthalmol 154: 200-205.e1.
28. Tsai DC, Huang CC, Chen SJ, Chou P, Chung CM, et al. (2012) Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study. Br J Ophthalmol 96: 1484-1488.
29. Tsai DC, Huang CC, Chen SJ, Chou P, Chung CM, et al. (2012) Increased risk of erectile dysfunction among males with central serous chorioretinopathy- a retrospective cohort study. Acta Ophthalmol In press.